Results 51 to 60 of about 2,399 (174)

Percepción de los profesionales médicos respecto la adherencia terapéutica de los pacientes con osteoporosis

open access: yesRevista de Osteoporosis y Metabolismo Mineral, 2016
Inroducción: La adherencia al tratamiento oral del paciente con osteoporosis es baja, con un alto porcentaje de abandonos durante el primer año. La consecuencia más notable es la falta de respuesta terapéutica.Objetivo: Conocer la percepción de los ...
Blanch J   +6 more
doaj  

Papel de los bisfosfonatos en la osteonecrosis mandibular

open access: yesPerinatología y Reproducción Humana, 2015
Los bisfosfonatos son fármacos utilizados en el manejo de los trastornos primarios y secundarios del hueso, principalmente en la osteoporosis, tanto local como general, enfermedades metabólicas óseas, calcificación de tejidos blandos y estados de ...
J. Hernández Reyna   +1 more
doaj   +1 more source

Osteoporose induzida por glicocorticóide [PDF]

open access: yes, 1999
Glucocorticoids (GC) are among the most widely used drugs, characterized by their anti-inflammatory potency, nevertheless their use are followed for many deleterious systemic effects.
Borba, Victoria Zeghbi Cochenski   +1 more
core   +3 more sources

Osteonecrose dos maxilares associada ao uso de bisfosfonatos: importante complicação do tratamento oncológico Bisphosphonate-associated jaws osteonecrosis: an important complication of oncology treatment

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2009
Os bisfosfonatos são um grupo de medicamentos utilizados no tratamento de doenças malignas metastáticas e em outras doenças ósseas como osteoporose e doença de Paget.
Marco Antonio T. Martins   +4 more
doaj  

Osteonecrose maxilar associada ao uso de bisfosfonatos Bisphosphonate-related osteonecrosis of the jaw

open access: yesRevista Brasileira de Reumatologia, 2012
Os bisfosfonatos (BFs) têm sido indicados para o tratamento de doenças do metabolismo ósseo. Atualmente, seu emprego terapêutico aumentou e, com ele, os efeitos adversos, dos quais um dos mais importantes é a indução da osteonecrose dos maxilares, uma ...
Mariana Aparecida Brozoski   +4 more
doaj   +1 more source

Prevención y tratamiento de la osteoporosis [PDF]

open access: yes, 2006
La prevención de la osteoporosis tiene por objetivo mantener una masa y una calidad óseas adecuadas para evitar la aparición de fracturas. Para ello deben aconsejarse las medidas habituales de salud: evitar el tabaco, consumo moderado de alcohol ...
Roig Vilaseca, Daniel
core   +1 more source

Variación del nivel de citoquinas en líquido sinovial de equinos con enfermedad articular tratados con bisfosfonatos [PDF]

open access: yes
Osteoarthritis is one of the most common joint diseases in sport horses and is also cause of great economic losses associated. Early diagnosis of this disease, which sometimes is not feasible with radiographic studies, brings the possibility of early ...
Caggiano, Nicolás   +5 more
core   +2 more sources

Bone mineral density in thalassemic children: a Brazilian experience [PDF]

open access: yes, 2008
Osteoporosis is characterized by low bone mass and disruption of bone architecture, resulting in greater bone fragility with increased risk of fractures. Bone disease is an important cause of morbidity in beta thalassemia major patients. Osteoporosis has
Cavalheiro, Rita de Cassia Rosario   +5 more
core   +3 more sources

Osteonecrosis of the jaws in patients treated with bisphosphonates [PDF]

open access: yes, 2012
The literature describes an increasing presence of bisphosphonate-induced osteonecrosis of the jaws (ONJ), characterized by the exposure for over 8 weeks of necrotic bone in the maxillofacial region, after bisphosphonate therapy, in the absence of ...
Ata-Ali Mahmud, Fadi   +3 more
core   +1 more source

Severe osteonecrosis of the jaws in a compromised patient subjected to bisphosphonate therapy

open access: yesRevista Cubana de Estomatología, 2014
Bisphosphonate-related osteonecrosis of the jaws is characterized by alveolar bone exposure, especially after mucosal trauma or after surgical procedures, in patients who have previously received or who are currently receiving bisphosphonates without a ...
Juliana Dreyer Menezes   +4 more
doaj  

Home - About - Disclaimer - Privacy